The FDA had halted use in older adults while it investigated reports of side effects. The vaccine’s label now carries new ...

The US Food and Drug Administration (FDA) has lifted a pause in the use of Valneva’s chikungunya vaccine Ixchiq in older ...

The FDA has removed the recommended pause in the use of Valneva’s chikungunya vaccine Ixchiq in individuals aged 60 years and older.

"Based on the available data, and its benefit-risk assessment, FDA has removed the recommended pause in the use of Ixchiq in ...

Experts say the painful infection, spread to people from mosquitoes, can get to many countries if it finds the right hosts ...

The U.S. Centers for Disease Control and Prevention is warning travelers about a new virus in China called chikungunya. In ...

The FDA has removed a pause in the use of Valneva’s chikungunya vaccine in older adults while tweaking the shot’s label with ...

Ixchiq now has a warning about its use among elderly people with multiple underlying health conditions after postmarketing ...

Valneva SE ( NASDAQ: VALN) said on Thursday that the FDA has lifted its pause on the use of its chikungunya vaccine, Ixchiq, ...

Follow the current Chikungunya virus outbreak in China, and learn why the mosquito-borne disease is on the rise.

Thousands of cases of the chikungunya virus, which sickens people bitten by an infected mosquito, have broken out in China ...